Biopol Chemicals IPO GMP

January 28, 2026 Written By Mihir Gohel, Reviewed and Fact Checked by Harpal Parmar

Biopol Chemicals IPO opens for subscription on February 6, 2026, and closes on February 10, 2026, with an issue size of ₹31.26 crore as a fresh issue listed on NSE SME. The company manufactures performance chemicals and additives for textiles, paper, leather, and water treatment industries, operating from advanced facilities with ISO certifications. Incorporated recently and based in India, Biopol Chemicals focuses on eco-friendly specialty chemicals serving domestic B2B clients. Biopol Chemicals IPO offers investors exposure to India’s specialty chemicals growth driven by industrial expansion and sustainability mandates.

₹00

Latest IPO GMP

Last updated on 01 Feb 2026 13.47

₹108

IPO Offer Price

*cut off price

₹

Listing Price

Listing Date 13/02/2026

Expert Opinions

Market sentiment for Biopol Chemicals IPO leans moderately positive among SME chemical investors, riding specialty additives demand despite pricing scrutiny noted in reviews. Company strengths encompass 66-product portfolio dominated by silicon-based textile/paper chemicals, ISO-certified manufacturing efficiency, and B2B relationships with consistent repeat orders. Risks include raw material dependency, environmental compliance costs, customer concentration exceeding 50%, and execution of ₹12.26 crore land acquisition.

Valuation analysis for Biopol Chemicals IPO and year 2025 indicates Return on Equity (ROE) of 38.10%, ROCE of 30.57%, and Net Asset Value (NAV) of ₹17.10, with post-issue P/E at 14.58x reflecting reasonable growth pricing. Long-term investment perspective merits consideration for industrial chemical tailwinds from textile exports and green manufacturing mandates.

Investor Considerations

Biopol Chemicals IPO investors should assess the company’s solid growth profile, with FY 2025 revenue surging 189% to ₹49.15 crore and PAT rising 46% to ₹4.33 crore, supported by EBITDA of ₹6.53 crore amid expanded textile chemical production. Specialty chemicals sector outlook benefits from 12% CAGR through 2030, driven by textile exports and industrial value addition.

Valuation analysis for Biopol Chemicals IPO in 2025 shows Price to Book Value of 6.31, PAT Margin of 8.81%, and Debt/Equity ratio of 0.57, reflecting premium efficiency with low leverage. Growth prospects include ₹12.26 crore land acquisition for backward integration and ₹6.25 crore working capital bolstering capacity. Risk factors comprise raw material volatility, customer concentration, and environmental regulations. Long-term investment goals align with chemical indigenization, while short-term strategies face SME liquidity hurdles.